These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Human megakaryocytes. III. Characterization in myeloproliferative disorders. Rabellino EM; Levene RB; Nachman RL; Leung LL Blood; 1984 Mar; 63(3):615-22. PubMed ID: 6230121 [TBL] [Abstract][Full Text] [Related]
8. Postmortem diagnosis of acute megakaryocytic leukemia. Usefulness of immunohistochemistry and tissue hemogram. Umezawa A; Yamada T; Ogawa Y; Kuramochi S; Watanabe Y Acta Pathol Jpn; 1990 Sep; 40(9):693-8. PubMed ID: 2260477 [TBL] [Abstract][Full Text] [Related]
9. Megakaryocytic myelosis in a cat. Michel RL; O'Handley P; Dade AW J Am Vet Med Assoc; 1976 Jun; 168(11):1021-5. PubMed ID: 931768 [TBL] [Abstract][Full Text] [Related]
10. An autopsy case of megakaryocytic myelosis. Iizumi T; Onishi Y; Higuchi M Acta Pathol Jpn; 1973 May; 23(2):367-83. PubMed ID: 4800539 [No Abstract] [Full Text] [Related]
11. Acute megakaryoblastic leukaemia: a clinico-haematological profile of five cases. Shukla J; Rai S; Singh VP Indian J Pathol Microbiol; 2004 Apr; 47(2):266-8. PubMed ID: 16295495 [TBL] [Abstract][Full Text] [Related]
12. Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts. Buhr T; Georgii A; Schuppan O; Amor A; Kaloutsi V Ann Hematol; 1992 Jun; 64(6):286-91. PubMed ID: 1637884 [TBL] [Abstract][Full Text] [Related]
13. Essential thrombocythemia. Clinical characteristics and course of 61 cases. Hehlmann R; Jahn M; Baumann B; Köpcke W Cancer; 1988 Jun; 61(12):2487-96. PubMed ID: 3365670 [TBL] [Abstract][Full Text] [Related]
14. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia. Thiele J; Funke S; Holgado S; Choritz H; Georgii A Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964 [TBL] [Abstract][Full Text] [Related]
15. The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states. Cashell AW; Buss DH Ann Hematol; 1992 Jun; 64(6):273-6. PubMed ID: 1637881 [TBL] [Abstract][Full Text] [Related]
16. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies]. Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999 [TBL] [Abstract][Full Text] [Related]
17. Megakaryocyte markers in myeloproliferative disorders. Iványi JL; Kiss A; Telek B; Tornai I Acta Histochem; 1993 Sep; 95(1):79-88. PubMed ID: 7506475 [TBL] [Abstract][Full Text] [Related]
18. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders]. Bobik R; Podolak-Dawidziak M; Kiełbiński M; Jeleń M; Wróbel T Acta Haematol Pol; 1995; 26(2):179-83. PubMed ID: 7653223 [TBL] [Abstract][Full Text] [Related]
19. Chronic megakaryocytic-granulocytic myelosis--an electron microscopic study. I. Megakaryocytes and thrombocytes. Thiele J; Ballard AC; Georgii A; Vykoupil KF Virchows Arch A Pathol Anat Histol; 1977 Apr; 373(3):191-211. PubMed ID: 140504 [TBL] [Abstract][Full Text] [Related]
20. Abnormalities of megakaryocytes in myelitis and chronic myeloproliferative diseases. Thiele J; Holgado S; Choritz H; Georgii A Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 41(1-2):67-81. PubMed ID: 6134385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]